National Health (Botulinum Toxin Program) Amendment Special Arrangement 2022 (Cth)

PB 129 of 2022

National Health (Botulinum Toxin Program) Amendment Special Arrangement 2022

I, Elsy Brammesan, delegate of the Minister for Health and Aged Care, make the following special arrangement.

Dated               16/12/2022                 

Elsy Brammesan

Acting Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Health Resourcing Group

Department of Health and Aged Care

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments  2

National Health (Botulinum Toxin Program) Special Arrangement 2015   2

1  Name

(1)This instrument is the National Health (Botulinum Toxin Program) Amendment Special Arrangement 2022.

(2)This instrument may also be cited as PB 129 of 2022.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 January 2023.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 100(2) of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Botulinum Toxin Program) Special Arrangement 2015

1  Subsection 9(1)

Repeal the subsection, substitute:

(1) A pharmaceutical benefit can only be supplied under this Special Arrangement by an approved hospital authority for a private hospital or public hospital:

(a) on receipt of a valid prescription for an eligible patient; or

(b) prior to the receipt of a valid prescription for an eligible patient, in circumstances where the eligible medical practitioner provides the prescription to the approved hospital authority within 7 days of the eligible medical practitioner treating the eligible patient with the pharmaceutical benefit.